As value-based health matures and expands from the physician practice market to the integrated delivery system market the need for integrated industrial strength data aggregation and warehousing, provided by Oracle, with the intellectual property and functionality for population health management, provided by Enli, is critical. Without this integrated capability healthcare delivery systems will be unable to scale their value-based health programs. Despite efforts by the current administration to dismantle the Affordable Care Act, IDC Health Insights believes value-based health will continue to grow and in the next five years become the dominant model for care and the financing of healthcare. Oracle will benefit from the partnership as they continue to build out their "healthcare offerings" to their global clients. Oracle offers global channel opportunities to Enli as well as the data infrastructure to scale Enli's Care Manager application into large complex delivery systems.
Some of the most promising digital solutions have come out of healthcare innovation labs across Europe in the recent years. When partnering with vendors, collaborating across Europe, and evaluating the technology through an academic assessment methodology, the healthcare innovations become sustainable and thereby subject to an enterprise wide adoption and replication on a European scale.
The IDC FutureScape: Worldwide Healthcare IT 2017 Predictions provides healthcare executives across the globe a guide to likely future technology and business scenarios. Executives can use this document as input to their IT strategy moving forward. The IDC Health Insights predictions are suggesting that the next three years will be focused on the adoption of disruptive technologies which will enable healthcare digital transformation. The drivers include the rise of computer-based intelligence with the increased adoption of cognitive/AI and robotics. The increased adoption of internet of things (IoT) technology is resulting in the convergence of mobile, social and sensors. The illness burden across the globe is continuing to increase with an aging population, an epidemic of chronic illness and the continued outbreak of infectious diseases will continue to drive healthcare technology innovation and force changes in reimbursement and contribute to shortages of medical and pharmaceutical resources.
While the healthcare industry is most visibly targeted with the promise to repeal Obamacare, the life science industry can expect to experience significant changes in the shadow of the 2016 elections.
The life science analyst team plans on diving more deeply into the topic over the next several weeks, but our high level view is that repatriation of off-shore revenue, weakening of the FDA, re-importation of drugs, and easing of calls for drug price controls will drive early, life science-related Trump presidency discussions and actions.
The quote "May you live in interesting times," is more relevant than ever. Stay tuned. As always, comments and alternative opinions are always welcome and appreciated.
As November 8th came to a close and electoral votes were being tallied across the country, the proverbial “shot heard around the world” was heard. Americans dissatisfied with the status quo and insider politics elected Donald J. Trump as the 45th president of the United States. IDC Health Insights reflects on the impact a Trump presidency will have on healthcare and healthcare IT initiatives.